FDA Stayed Silent As Internal Reports About Potential Tylenol Risks Piled Up

FDA Stayed Silent as Internal Reports About Potential Tylenol Risks Piled Up

Open the article to view the coverage from The Virginia Star

Maternal health: FDA stayed silent as internal reports about potential Tylenol risks piled up * WorldNetDaily * by Emily Kopp, Daily Caller News Foundation

Open the article to view the coverage from WND

FDA Stayed Silent As Internal Reports About Potential Tylenol Risks Piled Up

The FDA defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal documents reveal.